Biotech · Private company
GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
Track this companyFree. Adds GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- GB002 (seralutinib)Phase 2 · Pulmonary Artery HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Generic Dry Powder InhalerPhase 2 · Pulmonary Artery HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- GB002Phase 1 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- GB002Phase 1 · Safety IssuesClinicalTrials.gov · fetched Nov 12, 2026
- Generic Dry Powder InhalerPhase 1 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Generic Dry Powder InhalerPhase 1 · Safety IssuesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)PHASE2 · COMPLETED · started Nov 12, 2020ClinicalTrials.gov NCT04456998 · fetched Nov 12, 2026
- Clinical Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial HypertensionPHASE1 · COMPLETED · started Feb 4, 2020ClinicalTrials.gov NCT03926793 · fetched Nov 12, 2026
- Phase 1A Safety Trial of Inhaled PK10571 (GB002)PHASE1 · COMPLETED · started Sep 6, 2017ClinicalTrials.gov NCT03473236 · fetched Nov 12, 2026